Evidence map›Paper›PMID 35429974›Full record

Trial reportRespiratory research2022

A computerized tomography-based radiomic model for assessing the invasiveness of lung adenocarcinoma manifesting as ground-glass opacity nodules.

Minghui Zhu, Zhen Yang, Miaoyu Wang, Wei Zhao, Qiang Zhu, Wenjia Shi, Hang Yu, Zhixin Liang, Liangan Chen

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Respiratory research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Predicting malignant risk of ground-glass nodules using convolutional neural networks based on dual-time-pointCancer imaging : the official publication of the International Cancer Imaging Society · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Minghui Zhu *Chinese People's Liberation Army Medical School, Beijing, 100853, China.
Zhen Yang *Department of Respiratory Medicine, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, 100853, China.
Miaoyu WangDepartment of Respiratory Medicine, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, 100853, China.
Wei ZhaoDepartment of Respiratory Medicine, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, 100853, China.
Qiang ZhuDepartment of Respiratory Medicine, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, 100853, China.
Wenjia ShiDepartment of Respiratory Medicine, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, 100853, China.
Hang YuDepartment of Respiratory Medicine, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, 100853, China.
Zhixin LiangDepartment of Respiratory Medicine, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, 100853, China.
Liangan ChenDepartment of Respiratory Medicine, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, 100853, China. chenliangan301@163.com.

Funding

Beijing Capital Development Special Project for Health Research 2020-1-5011Big Data Project of Chinese People's Liberation Army General Hospital 2019MBD-052
6 · The paper itself

Abstract

backgroundClinically differentiating preinvasive lesions (atypical adenomatous hyperplasia, AAH and adenocarcinoma in situ, AIS) from invasive lesions (minimally invasive adenocarcinomas, MIA and invasive adenocarcinoma, IA) manifesting as ground-glass opacity nodules (GGOs) is difficult due to overlap of morphological features. Hence, the current study was performed to explore the diagnostic efficiency of radiomics in assessing the invasiveness of lung adenocarcinoma manifesting as GGOs.

methodsA total of 1018 GGOs pathologically confirmed as lung adenocarcinoma were enrolled in this retrospective study and were randomly divided into a training set (n = 712) and validation set (n = 306). The nodules were delineated manually and 2446 intra-nodular and peri-nodular radiomic features were extracted. Univariate analysis and least absolute shrinkage and selection operator (LASSO) were used for feature selection. Clinical and semantic computerized tomography (CT) feature model, radiomic model and a combined nomogram were constructed and compared. Decision curve analysis (DCA) was used to evaluate the clinical value of the established nomogram.

results16 radiomic features were selected and used for model construction. The radiomic model exhibited significantly better performance (AUC = 0.828) comparing to the clinical-semantic model (AUC = 0.746). Further analysis revealed that peri-nodular radiomic features were useful in differentiating between preinvasive and invasive lung adenocarcinomas appearing as GGOs with an AUC of 0.808. A nomogram based on lobulation sign and radiomic features showed the best performance (AUC = 0.835), and was found to have potential clinical value in assessing nodule invasiveness.

conclusionsRadiomic model based on both intra-nodular and peri-nodular features showed good performance in differentiating between preinvasive lung adenocarcinoma lesions and invasive ones appearing as GGOs, and a nomogram based on clinical, semantic and radiomic features could provide clinicians with added information in nodule management and preoperative evaluation.

Indexed as

AdenocarcinomaAdenocarcinoma of LungLung NeoplasmsHumansNeoplasm InvasivenessRetrospective StudiesTomography, X-Ray ComputedComputerized tomographyGround-glass opacity nodulesInvasivenessLung adenocarcinomaRadiomics

Identifiers

PMID35429974
PMCPMC9013452

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.